Most cited papers from Tennessee Retina

The most cited paper from Tennessee Retina is "Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study" (Peter A. Campochiaro, David M. Brown, Carl C. Awh et al., 2011), with 709 citations. Next come "Spectrum and Susceptibilities of Microbiologic Isolates in the Endophthalmitis Vitrectomy Study" (705) and "Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration" (590).

Showing 50 of 60 papers. Every paper with more than 40 citations is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.